Form D · Pharmaceuticals
Sonnet Biotherapeutics, Inc.
Princeton, NJ · CIK 0001776628
Offering snapshot reported May 14, 2019 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2019 | Initial | $750,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339578
Source: Form D, filed May 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Cini | Executive |
| Susan Dexter | Executive |
| Donald Griffith | Executive |
| Pankaj Mohan | Director, Executive |
| Terence Rugg | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Overlook Center Second Floor
Princeton, NJ, 08540
Princeton, NJ, 08540